Bruker (NASDAQ:BRKR) updated its FY 2019 earnings guidance on Monday. The company provided earnings per share (EPS) guidance of $1.54-1.58 for the period, compared to the Thomson Reuters consensus estimate of $1.55. The company issued revenue guidance of $2.009-2.028 billion, compared to the consensus revenue estimate of $1.97 billion.
Several analysts have weighed in on the company. Zacks Investment Research downgraded Bruker from a buy rating to a hold rating in a research note on Wednesday, January 30th. BidaskClub upgraded Bruker from a hold rating to a buy rating in a research note on Wednesday, November 7th. ValuEngine downgraded Bruker from a buy rating to a hold rating in a research note on Thursday, November 15th. Finally, Needham & Company LLC assumed coverage on Bruker in a research note on Wednesday, January 2nd. They set a strong-buy rating and a $39.00 price target on the stock. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company. Bruker has an average rating of Hold and a consensus price target of $35.83.
Shares of BRKR stock traded up $0.19 on Monday, hitting $35.53. The company had a trading volume of 979,312 shares, compared to its average volume of 681,347. The stock has a market cap of $5.53 billion, a PE ratio of 29.36, a price-to-earnings-growth ratio of 1.87 and a beta of 1.49. The company has a quick ratio of 1.32, a current ratio of 2.24 and a debt-to-equity ratio of 0.27. Bruker has a twelve month low of $26.10 and a twelve month high of $35.96.
Bruker Corporation manufactures and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates in two segments, Bruker Scientific Instruments, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry systems; infrared spectroscopy and radiological/nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection in emergency response, homeland security, and defense applications; and research, analytical, and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies.
Further Reading: Technical Analysis of Stocks and What It Means
Receive News & Ratings for Bruker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker and related companies with MarketBeat.com's FREE daily email newsletter.